Two Sigma Advisers’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-105,544
| Closed | -$992K | – | 2687 |
|
|
2020
Q3 | $992K | Sell |
105,544
-87,600
| -45% | -$833K | ﹤0.01% | 1502 |
|
|
2020
Q2 | $1.48M | Sell |
193,144
-13,200
| -6% | -$101K | ﹤0.01% | 1382 |
|
|
2020
Q1 | $1.27M | Sell |
206,344
-34,800
| -14% | -$307K | ﹤0.01% | 1350 |
|
|
2019
Q4 | $2.94M | Sell |
241,144
-19,700
| -8% | -$215K | 0.01% | 1060 |
|
|
2019
Q3 | $3.01M | Sell |
260,844
-57,100
| -18% | -$601K | 0.01% | 952 |
|
|
2019
Q2 | $3.18M | Buy |
317,944
+214,600
| +208% | +$2.32M | 0.01% | 1011 |
|
|
2019
Q1 | $1.33M | Buy |
103,344
+75,744
| +274% | +$1.13M | ﹤0.01% | 1396 |
|
|
2018
Q4 | $419K | Buy |
27,600
+15,400
| +126% | +$293K | ﹤0.01% | 1843 |
|
|
2018
Q3 | $244K | Sell |
12,200
-67,300
| -85% | -$1.53M | ﹤0.01% | 2022 |
|
|
2018
Q2 | $1.55M | Buy |
79,500
+61,000
| +330% | +$1.35M | ﹤0.01% | 1418 |
|
|
2018
Q1 | $373K | Buy |
18,500
+700
| +4% | +$11.8K | ﹤0.01% | 1937 |
|
|
2017
Q4 | $236K | Sell |
17,800
-9,500
| -35% | -$143K | ﹤0.01% | 2032 |
|
|
2017
Q3 | $504K | Buy |
27,300
+9,500
| +53% | +$177K | ﹤0.01% | 1747 |
|
|
2017
Q2 | $328K | Buy |
17,800
+100
| +0.6% | +$1.98K | ﹤0.01% | 1955 |
|
|
2017
Q1 | $399K | Buy |
17,700
+6,656
| +60% | +$159K | ﹤0.01% | 1984 |
|
|
2016
Q4 | $384K | Buy |
+11,044
| New | +$330K | ﹤0.01% | 1992 |
|
|
2015
Q3 | – | Sell |
-25,846
| Closed | -$1.78M | – | 2064 |
|
|
2015
Q2 | $1.78M | Buy |
25,846
+21,000
| +433% | +$1.32M | 0.01% | 858 |
|
|
2015
Q1 | $265K | Sell |
4,846
-16,100
| -77% | -$767K | ﹤0.01% | 1632 |
|
|
2014
Q4 | $893K | Buy |
+20,946
| New | +$757K | 0.01% | 1233 |
|
|
2014
Q3 | – | Sell |
-27,646
| Closed | -$573K | – | 2774 |
|
|
2014
Q2 | $573K | Buy |
27,646
+11,400
| +70% | +$211K | ﹤0.01% | 1571 |
|
|
2014
Q1 | $315K | Sell |
16,246
-8,500
| -34% | -$181K | ﹤0.01% | 1840 |
|
|
2013
Q4 | $601K | Buy |
24,746
+200
| +0.8% | +$4.7K | 0.01% | 1482 |
|
|
2013
Q3 | $527K | Sell |
24,546
-2,900
| -11% | -$68.5K | 0.01% | 1348 |
|
|
2013
Q2 | $610K | Buy |
+27,446
| New | +$605K | 0.01% | 1197 |
|
Two Sigma Advisers's AMAG Position: Q4 2020 in Review
Two Sigma Advisers sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 105,544 shares — an estimated $992K sold.
Two Sigma Advisers first reported a position in AMAG in Q2 2013 and held it in 24 quarters. The position peaked at $3.18M in Q2 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Two Sigma Advisers reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Two Sigma Advisers sold 105,544 AMAG Pharmaceuticals shares in Q4 2020, an estimated $992K.
- Two Sigma Advisers first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 24 quarters.
- Two Sigma Advisers's AMAG Pharmaceuticals position peaked at $3.18M in Q2 2019.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.